Canadian recommendations for the use of angiotensin receptor neprilysin inhibitor and GLP-1 RA in the management of heart failure with mildly reduced or preserved ejection fraction

29 August 2026 (17:45 - 18:00)
Organised by: Logo
Congress Presentation Part of: Pharmacologic management of heart failure with mildly reduced or preserved ejection fraction Treatment ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology